1. Home
  2. Labeler Index
  3. Poly Pharmaceuticals, Inc.
  4. 50991-999
  5. NDC Package Code: 50991-999-60 Norgesic Forte

NDC Package 50991-999-60 Norgesic Forte

Orphenadrine Citrate,Aspirin And Caffeine Tablet, Multilayer Oral - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
50991-999-60
Package Description:
60 TABLET, MULTILAYER in 1 BOTTLE
Product Code:
50991-999
Proprietary Name:
Norgesic Forte
Non-Proprietary Name:
Orphenadrine Citrate, Aspirin And Caffeine
Substance Name:
Aspirin; Caffeine; Orphenadrine Citrate
Usage Information:
Norgesic Forte 50 mg/770mg/60 mg Tablets are indicated in:Symptomatic relief of mild to moderate pain of acute musculoskeletal disorders.The orphenadrine component is indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute painful musculoskeletal conditions. The mode of action of orphenadrine has not been clearly identified, but may be related to its analgesic properties. Norgesic Forte Tablets do not directly relax tense skeletal muscles in man.
11-Digit NDC Billing Format:
50991099960
Billing Unit:
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
NDC to RxNorm Crosswalk:
60 EA
NDC to RxNorm Crosswalk:
  • RxCUI: 994535 - orphenadrine citrate 50 MG / aspirin 770 MG / caffeine 60 MG Oral Tablet
  • RxCUI: 994535 - aspirin 770 MG / caffeine 60 MG / orphenadrine citrate 50 MG Oral Tablet
  • RxCUI: 994535 - ASA 770 MG / caffeine 60 MG / orphenadrine citrate 50 MG Oral Tablet
  • RxCUI: 994537 - Norgesic Forte 50 MG / 770 MG / 60 MG Oral Tablet
  • RxCUI: 994537 - aspirin 770 MG / caffeine 60 MG / orphenadrine citrate 50 MG Oral Tablet [Norgesic]
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Poly Pharmaceuticals, Inc.
    Dosage Form:
    Tablet, Multilayer - A solid dosage form containing medicinal substances that have been compressed to form a multiple-layered tablet or a tablet-within-a-tablet, the inner tablet being the core and the outer portion being the shell.
    Administration Route(s):
  • Oral - Administration to or by way of the mouth.
    • Active Ingredient(s):
  • ASPIRIN 770 mg/1
  • CAFFEINE 60 mg/1
  • ORPHENADRINE CITRATE 50 mg/1
    • Pharmacologic Class(es):
  • Anti-Inflammatory Agents, Non-Steroidal - [CS]
  • Central Nervous System Stimulant - [EPC] (Established Pharmacologic Class)
  • Central Nervous System Stimulation - [PE] (Physiologic Effect)
  • Centrally-mediated Muscle Relaxation - [PE] (Physiologic Effect)
  • Cyclooxygenase Inhibitors - [MoA] (Mechanism of Action)
  • Decreased Platelet Aggregation - [PE] (Physiologic Effect)
  • Decreased Prostaglandin Production - [PE] (Physiologic Effect)
  • Methylxanthine - [EPC] (Established Pharmacologic Class)
  • Muscle Relaxant - [EPC] (Established Pharmacologic Class)
  • Nonsteroidal Anti-inflammatory Drug - [EPC] (Established Pharmacologic Class)
  • Platelet Aggregation Inhibitor - [EPC] (Established Pharmacologic Class)
  • Xanthines - [CS]
    • Sample Package:
    No
    FDA Application Number:
    ANDA075141
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    04-01-2019
    Listing Expiration Date:
    12-31-2025
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    50991-999-066 TABLET, MULTILAYER in 1 CARTON

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 50991-999-60?

    The NDC Packaged Code 50991-999-60 is assigned to a package of 60 tablet, multilayer in 1 bottle of Norgesic Forte, a human prescription drug labeled by Poly Pharmaceuticals, Inc.. The product's dosage form is tablet, multilayer and is administered via oral form.This product is billed for "EA" each discreet unit and contains an estimated amount of 60 billable units per package.

    Is NDC 50991-999 included in the NDC Directory?

    Yes, Norgesic Forte with product code 50991-999 is active and included in the NDC Directory. The product was first marketed by Poly Pharmaceuticals, Inc. on April 01, 2019 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 50991-999-60?

    The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 60.

    What is the 11-digit format for NDC 50991-999-60?

    The 11-digit format is 50991099960. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-250991-999-605-4-250991-0999-60